Expression and clinical significance of MicroRNA-376a in colorectal cancer

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 21, 2014, Pages 9523-9527

  Mo, Zhan Hao ^a   Wu, Xiao Dong ^a   Li, Shuo ^a   Fei, Bing Yuan ^a   Zhang, Bin ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Clinicopathology; Colorectal cancer; microRNA; Vascular endothelial growth factor

Indexed keywords

MICRORNA; MIRN376 MICRORNA, HUMAN; TUMOR MARKER; VASCULOTROPIN A;

BIOSYNTHESIS; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SURVIVAL;

COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84918522240     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.21.9523     Document Type: Article

References (29)

1. Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97.
2. Brennecke J, Hipfner DR, Stark A, et al (2003). bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell, 113, 25-36.
3. Bruderer M, Alini M, Stoddart MJ (2013). Role of HOXA9 and VEZF1 in endothelial biology. J Vasc Res, 50, 265-78.
4. Cuk K, Zucknick M, Madhavan D, et al (2013). Plasma microRNA panel for minimally invasive detection of breast cancer. PLoS One, 8, 76729.
5. Farazi TA, Spitzer JI, Morozov P, et al (2011). miRNAs in human cancer. J Pathol, 223, 102-15.
6. Kelley RK, Wang G, Venook AP (2011). Biomarker use in colorectal cancer therapy. J Natl Compr Canc Netw, 9, 1293-302.
7. Kunte DP, DelaCruz M, Wali RK, et al (2012). Dysregulation of microRNAs in colonic field carcinogenesis: implications for screening. PLoS One, 7, 45591.
8. Liu K, Li G, Fan C, et al (2012). Increased expression of microRNA-221 in gastric cancer and its clinical significance. J Int Med Res, 40, 467-74.
9. Liu Y, Zhou Y, Feng X, et al (2014). Low expression of microRNA-126 is associated with poor prognosis in colorectal cancer. Genes Chromosomes Cancer, 53, 358-65.
10. Lou X, Qi X, Zhang Y, et al (2013). Decreased expression of microRNA-625 is associated with tumor metastasis and poor prognosis in patients with colorectal cancer. J Surg Oncol, 108, 230-5.
11. Lu S, Wang S, Geng S, et al (2013). Upregulation of microRNA-224 confers a poor prognosis in glioma patients. Clin Transl Oncol, 15, 569-74.
12. Luo X, Burwinkel B, Tao S, et al (2011). MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol Biomarkers Prev, 20, 1272-86.
13. Ng SC, Wong SH (2013). Colorectal cancer screening in Asia. Br Med Bull, 105, 29-42.
14. Nishimura J, Handa R, Yamamoto H, et al (2012). microRNA-181a is associated with poor prognosis of colorectal cancer. Oncol Rep, 28, 2221-6.
15. Peng HH, Zhang YD, Gong LS, et al (2013). Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma. Onco Targets Ther, 6, 1625-30.
16. Shen SN, Wang LF, Jia YF, et al (2013). Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer. Diagn Pathol, 8, 69.
17. Sung JJ, Lau JY, Goh KL, et al (2005). Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol, 6, 871-6.
18. Toyama T, Kondo N, Endo Y, et al (2012). High expression of microRNA-210 is an independent factor indicating a poor prognosis in Japanese triple-negative breast cancer patients. Jpn J Clin Oncol, 42, 256-63.
19. van den Berg A, Mols J, Han J (2008). RISC-target interaction: cleavage and translational suppression. Biochim Biophys Acta, 1779, 668-77.
20. Wan SM, Lv F, Guan T (2012). Identification of genes and microRNAs involved in ovarian carcinogenesis. Asian Pac J Cancer Prev, 13, 3997-4000.
21. Wang S, Li Q, Wang K, et al (2013). Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer. Clin Transl Oncol, 15, 849-54.
22. Warren RS, Yuan H, Matli MR, et al (1996). Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J Biol Chem, 271, 29483-8.
23. Wu W, Yang J, Feng X, et al (2013a). MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells. Mol Cancer, 12, 30.
24. Wu W, Yang P, Feng X, et al (2013b). The relationship between and clinical significance of MicroRNA-32 and phosphatase and tensin homologue expression in colorectal cancer. Genes Chromosomes Cancer, 52, 1133-40.
25. Xiao ZG, Deng ZS, Zhang YD, et al (2013). Clinical significance of microRNA-93 downregulation in human colon cancer. Eur J Gastroenterol Hepatol, 25, 296-301.
26. Xu T, Liu X, Han L, et al (2014). Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer. Clin Transl Oncol, 16, 469-75.
27. Zehavi L, Avraham R, Barzilai A, et al (2012). Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor. Mol Cancer, 11, 44.
28. Zhao BS, Liu SG, Wang TY, et al (2013). Screening of microRNA in patients with esophageal cancer at same tumor node metastasis stage with different prognoses. Asian Pac J Cancer Prev, 14, 139-43.
29. Zheng Y, Yin L, Chen H, et al (2012). miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma. FEBS Lett, 586, 2396-403.